| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Dec 4, 2024 | BeOne Medicines Ltd. | 10% Owner | Sell | 15.0 | -17,842,500 | -12.49% | ✗ | $3.6B |
| Jan 30, 2024 | Feb 1, 2024 | ArriVent BioPharma, Inc. | 10% Owner | Buy | 100.0 | +555,555 | 14.14% | ✗ | $10M |
| Jun 13, 2023 | Jun 15, 2023 | BeOne Medicines Ltd. | 10% Owner | Sell | 25.0 | -1,198,128 | -0.83% | ✗ | $226.3M |
| Jun 8, 2023 | Jun 12, 2023 | BeOne Medicines Ltd. | 10% Owner | Sell | 15.0 | -2,956,689 | -2.01% | ✗ | $597.2M |